July 2026
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
April 2026
The global chemical API CDMO market size was evaluated at USD 16.80 billion in 2025 and is predicted to hit around USD 40.88 billion by 2035, growing at a CAGR of 9.30%.
July 2026
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
June 2025
The global topical drugs CDMO market size was exhibited at USD 46.62 billion in 2024 and is predicted to surpass around USD 136.39 billion by 2034, with a CAGR of 11.33%.
July 2026
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
July 2026
Explore the cosmeceutical API market trends, size, and future outlook. Stay ahead with insights into active ingredients driving skincare innovations.
July 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
July 2026
API Security and Management Market grows with digital integration, zero-trust security models, and rising API-based applications.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global small molecule innovator CDMO market size is valued at USD 56.41 billion in 2025 and is projected to hit around USD 103.22 billion by 2035 with a CAGR of 6.23%.
June 2026
The global sterile injectables CDMO market size is estimated to hit around USD 11.82 billion by 2035 from USD 4.73 billion in 2025, with a CAGR of 9.59%.
June 2026
The global synthetic small molecule API market size is estimated to hit around USD 342.63 billion by 2035 increasing from USD 197.21 billion in 2025, with a CAGR of 5.68%.
June 2026
The global human capital management market size is projected to surpass around USD 81.41 billion by 2035 from USD 34.37 billion in 2025 with a notable CAGR of 9.01%%.
June 2026
The rapid diagnostics market size was estimated at USD 51.12 billion in 2025 and is projected to surpass around USD 322.71 billion in 2035 with a solid CAGR of 20.23%.
June 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
June 2026
The global pharmaceutical CDMO for formulations market size is accounted to hit around USD 103.33 billion by 2035, increasing from USD 48.85 billion in 2025, with a CAGR of 7.78%.
June 2026
The global small molecule API market size was valued at USD 205.69 billion in 2025 and is projected to surpass around USD 347.45 billion by 2035 with a CAGR of 5.38%.
June 2026
The global AI-integrated CDMO process optimization market is growing as contract manufacturers adopt AI to streamline drug development and manufacturing workflows.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
June 2026
The RNA editing therapies market expands with clinical progress in precision therapeutics, rare disease solutions, and gene-based medicine.
June 2026
The global peptide api market size is estimated to hit around USD 100.16 billion by 2035, increasing from USD 62.01 billion in 2025, with a CAGR of 4.91%.
June 2026
The global oral cancer rapid test kit market size is estimated to hit around USD 3.94 billion by 2035 increasing from USD 2.38 billion in 2025, with a CAGR of 5.17%.
June 2026
The global rapid microbiology testing market size is expected to increase to USD 12.72 billion by 2035 from USD 6.75 billion in 2025 with a notable CAGR of 6.54%.
May 2026
The global peptide therapeutics contract API manufacturing market size is estimated to hit around USD 9.02 billion by 2035 from USD 3.84 billion in 2025, at a CAGR of 9.02%.
May 2026
The global healthcare API market size is projected to hit around USD 348.4 million by 2035 from USD 243.56 million in 2025, growing at a CAGR of 3.64%.
May 2026
Europe Pharmaceutical CDMO market size is projected to hit around USD 94.94 billion by 2035, rising from USD 45.68 billion in 2025, growing at a CAGR of 7.59%.
May 2026
The global active pharmaceutical ingredients CDMO market size is evaluated at USD 116.77 billion in 2025 and is predicted to hit around USD 231.48 billion by 2035, growing at a CAGR of 7.81%.
May 2026
The global CAR-T therapies for blood cancers market size was evaluated at USD 6.80 billion in 2025 and is predicted to hit around USD 38.40 billion by 2035, growing at a CAGR of 18.90%.
April 2026
The global chemical drug CDMO market size was evaluated at USD 13.20 billion in 2025 and is predicted to hit around USD 29.84 billion by 2035, growing at a CAGR of 8.50%.
April 2026
The global veterinary API market size is estimated to hit around USD 9.25 billion by 2035 increasing from USD 5.62 billion in 2025, with a CAGR of 5.11%.